WO2004072232A3 - Covalent tethering of functional groups to proteins - Google Patents

Covalent tethering of functional groups to proteins Download PDF

Info

Publication number
WO2004072232A3
WO2004072232A3 PCT/US2004/002607 US2004002607W WO2004072232A3 WO 2004072232 A3 WO2004072232 A3 WO 2004072232A3 US 2004002607 W US2004002607 W US 2004002607W WO 2004072232 A3 WO2004072232 A3 WO 2004072232A3
Authority
WO
WIPO (PCT)
Prior art keywords
functional groups
proteins
hydrolase
substrate
bond
Prior art date
Application number
PCT/US2004/002607
Other languages
French (fr)
Other versions
WO2004072232A2 (en
WO2004072232A9 (en
Inventor
Keith V Wood
Georgyi V Los
Robert F Bulleit
Dieter Klaubert
Mark Mcdougall
Chad Zimprich
Original Assignee
Promega Corp
Keith V Wood
Georgyi V Los
Robert F Bulleit
Dieter Klaubert
Mark Mcdougall
Chad Zimprich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp, Keith V Wood, Georgyi V Los, Robert F Bulleit, Dieter Klaubert, Mark Mcdougall, Chad Zimprich filed Critical Promega Corp
Priority to AU2004211584A priority Critical patent/AU2004211584B2/en
Priority to CA002514564A priority patent/CA2514564A1/en
Priority to EP04707032.1A priority patent/EP1594962B1/en
Priority to JP2006503174A priority patent/JP4748685B2/en
Publication of WO2004072232A2 publication Critical patent/WO2004072232A2/en
Publication of WO2004072232A9 publication Critical patent/WO2004072232A9/en
Publication of WO2004072232A3 publication Critical patent/WO2004072232A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y308/00—Hydrolases acting on halide bonds (3.8)
    • C12Y308/01—Hydrolases acting on halide bonds (3.8) in C-halide substances (3.8.1)
    • C12Y308/01005—Haloalkane dehalogenase (3.8.1.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Abstract

A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
PCT/US2004/002607 2003-01-31 2004-01-30 Covalent tethering of functional groups to proteins WO2004072232A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2004211584A AU2004211584B2 (en) 2003-01-31 2004-01-30 Covalent tethering of functional groups to proteins
CA002514564A CA2514564A1 (en) 2003-01-31 2004-01-30 Covalent tethering of functional groups to proteins
EP04707032.1A EP1594962B1 (en) 2003-01-31 2004-01-30 Covalent tethering of functional groups to proteins
JP2006503174A JP4748685B2 (en) 2003-01-31 2004-01-30 Covalent tethering of functional groups to proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44409403P 2003-01-31 2003-01-31
US60/444,094 2003-01-31
US47465903P 2003-05-30 2003-05-30
US60/474,659 2003-05-30

Publications (3)

Publication Number Publication Date
WO2004072232A2 WO2004072232A2 (en) 2004-08-26
WO2004072232A9 WO2004072232A9 (en) 2004-10-14
WO2004072232A3 true WO2004072232A3 (en) 2005-01-27

Family

ID=32871922

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/002607 WO2004072232A2 (en) 2003-01-31 2004-01-30 Covalent tethering of functional groups to proteins

Country Status (7)

Country Link
US (9) US7238842B2 (en)
EP (5) EP2341134B1 (en)
JP (1) JP4748685B2 (en)
KR (1) KR20050109934A (en)
AU (1) AU2004211584B2 (en)
CA (1) CA2514564A1 (en)
WO (1) WO2004072232A2 (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072232A2 (en) 2003-01-31 2004-08-26 Promega Corporation Covalent tethering of functional groups to proteins
US7429472B2 (en) * 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
EP3179252B1 (en) * 2004-07-30 2018-11-14 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US20070087400A1 (en) * 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
EP1821094A1 (en) * 2004-12-07 2007-08-22 Effector Cell Institute, Inc. Cell measuring method
US20090130130A1 (en) * 2005-06-10 2009-05-21 National University Of Singapore Mutant allergen(s)
FR2890446B1 (en) 2005-09-05 2008-04-18 Cis Bio Internat Sa METHOD FOR DETECTING INTRACELLULAR INTERACTION BETWEEN BIO-MOLECULES
EP1945262A2 (en) * 2005-10-20 2008-07-23 The Scripps Research Institute Fc labeling for immunostaining and immunotargeting
CA2635747A1 (en) 2006-01-04 2007-07-19 Stanford University Self-illuminating quantum dot systems and methods of use thereof
EP1989548A2 (en) * 2006-02-08 2008-11-12 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules
US7449299B2 (en) * 2006-03-10 2008-11-11 David Bauer Quantum dot nanoparticle-based universal neurotoxin biosensor
JP5409354B2 (en) * 2006-05-25 2014-02-05 インスティチュート フォー アドバンスド スタディ Methods for identifying sequence motifs and their applications
DE102006045607A1 (en) * 2006-09-25 2008-03-27 Leica Microsystems Cms Gmbh Method for spatially high-resolution examination of a structure of a sample labeled with a fluorescent substance
EP2087107A2 (en) 2006-10-30 2009-08-12 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression
FR2934684B1 (en) 2008-07-31 2012-11-16 Cis Bio Int METHOD OF DETECTING INTERNALIZATION OF MEMBRANE PROTEINS.
EP2425249B1 (en) 2009-04-30 2014-07-16 Cisbio Bioassays Method for detecting compounds modulating dimers of vft domain membrane proteins
FR2949156B1 (en) 2009-08-13 2016-04-15 Cis-Bio Int METHOD FOR DETERMINING THE BINDING OF A COMPOUND GIVEN TO A MEMBRANE RECEPTOR
US8476014B2 (en) * 2010-02-19 2013-07-02 Los Alamos National Security, Llc Probe and method for DNA detection
BR112013010855A2 (en) 2010-11-02 2017-06-27 Promega Corp oplophorus-derived luciferases, novel coelenterazine substrates and methods of use
SG189494A1 (en) 2010-11-02 2013-05-31 Promega Corp Coelenterazine derivatives and methods of using same
US9500653B2 (en) 2010-12-07 2016-11-22 Yale University Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
FR2980271B1 (en) 2011-09-16 2013-10-11 Cisbio Bioassays METHOD FOR DETERMINING GLYCOSYLATION OF ANTIBODY
WO2013078244A1 (en) 2011-11-21 2013-05-30 Promega Corporation Carboxy x rhodamine analogs
EP2823270B1 (en) 2012-03-09 2022-05-04 Promega Corporation pH SENSORS
US9267117B2 (en) 2012-03-15 2016-02-23 New England Biolabs, Inc. Mapping cytosine modifications
FR2988174B1 (en) 2012-03-19 2014-04-25 Cisbio Bioassays METHOD FOR DETERMINING THE CAPACITY OF ANTIBODY TO MAINTAIN CELLS CLOSE TO EACH OTHER
US9585975B2 (en) * 2012-04-27 2017-03-07 Northwestern University MRI contrast agents
KR101923632B1 (en) 2012-07-31 2018-12-03 이스케이프 테라퓨틱스, 인코퍼레이티드 Hla g-modified cells and methods
WO2014035712A1 (en) 2012-08-28 2014-03-06 Pierce Biotechnology, Inc. Benzopyrylium compounds
SG11201504520XA (en) 2012-12-12 2015-07-30 Promega Corp Compositions and methods for capture of cellular targets of bioactive agents
US11072811B2 (en) 2013-03-15 2021-07-27 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
EP3312295A1 (en) 2013-03-19 2018-04-25 Directed Genomics, LLC Enrichment of target sequences
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3099691B1 (en) 2014-01-29 2019-11-20 Promega Corporation Pro-substrates for live cell applications
WO2015164972A1 (en) * 2014-04-30 2015-11-05 Lanxess Inc. Diluent for the production of butyl rubber
WO2016093838A1 (en) 2014-12-11 2016-06-16 New England Biolabs, Inc. Enrichment of target sequences
US10618907B2 (en) 2015-06-05 2020-04-14 Promega Corporation Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
EP3430015A1 (en) 2016-03-16 2019-01-23 Oryzon Genomics, S.A. Methods to determine kdm1a target engagement and chemoprobes useful therefor
EP3429575A4 (en) * 2016-03-16 2019-10-23 Purdue Research Foundation Carbonic anhydrase ix targeting agents and methods
CN113444094B (en) 2016-07-20 2023-12-22 纳莹(上海)生物科技有限公司 Fluorescent probe and preparation method and application thereof
EP3580563A4 (en) 2017-02-09 2020-11-18 Promega Corporation Analyte detection immunoassay
US20200278351A1 (en) * 2017-06-23 2020-09-03 Nanotemper Technologies Gmbh Methods for measuring inter- and/or intra-molecular interactions
CN109574880B (en) 2017-09-29 2022-06-17 纳莹(上海)生物科技有限公司 Fluorescent probe and preparation method and application thereof
CN110498799B (en) 2018-05-18 2022-07-05 纳莹(上海)生物科技有限公司 Fluorescent probe and preparation method and application thereof
EP3803401A4 (en) 2018-05-30 2022-02-23 Promega Corporation Broad-spectrum kinase binding agents
US20200200765A1 (en) 2018-12-04 2020-06-25 Promega Corporation Broad spectrum gpcr binding agents
JP2022526907A (en) 2019-03-20 2022-05-27 プロメガ コーポレイション Photoaffinity probe
US20220275350A1 (en) 2019-04-16 2022-09-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. Circularly permutated haloalkane transferase fusion molecules
EP3816180A1 (en) 2019-10-31 2021-05-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Circularly permutated haloalkane transferase fusion molecules
CN110646417B (en) * 2019-10-24 2021-10-15 福建医科大学 Rapid pyridoxal phosphate determination method taking nanogold as chromogenic probe
WO2021119149A1 (en) 2019-12-10 2021-06-17 Promega Corporation Compositions and methods for bioluminescent detection using multifunctional probes
EP4118233A1 (en) 2020-03-12 2023-01-18 New England Biolabs, Inc. A rapid diagnostic test for lamp
EP4153770A2 (en) 2020-05-22 2023-03-29 Promega Corporation Enhancement of kinase target engagement
WO2022040443A2 (en) 2020-08-21 2022-02-24 New England Biolabs, Inc. A rapid diagnostic test for lamp
WO2022047186A1 (en) 2020-08-28 2022-03-03 Promega Corporation Target engagement assay for ras proteins
KR20230147105A (en) 2021-01-28 2023-10-20 진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. Ligase fusion proteins and their applications
US20230203562A1 (en) 2021-12-28 2023-06-29 Encodia, Inc. High-throughput serotyping and antibody profiling assays
WO2023215452A2 (en) 2022-05-04 2023-11-09 Promega Corporation Split modified dehalogenase variants
WO2023215432A1 (en) 2022-05-04 2023-11-09 Promega Corporation Circularly permuted dehalogenase variants
WO2023215497A1 (en) 2022-05-04 2023-11-09 Promega Corporation Photoactivatable compounds and uses thereof
WO2023215505A1 (en) 2022-05-04 2023-11-09 Promega Corporation Modified dehalogenase with extended surface loop regions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060415A1 (en) * 2000-02-18 2001-08-23 The Immune Response Corporation Methods and compositions for gene delivery

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1229532B (en) 1961-04-14 1966-12-01 Boehringer Sohn Ingelheim Process for the preparation of new piperidine derivatives
US3131122A (en) * 1961-04-14 1964-04-28 Boehringer Sohn Ingelheim Method of producing analgesia with n-substituted-4-phenyl-4-carbalkoxypiperidines
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
US4612302A (en) 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4684620A (en) 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4812409A (en) 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
DE3614647A1 (en) * 1986-04-30 1987-11-05 Euratom 7-PHENYL ACETIC ACID-4-ALKYL-COUMARINYLAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN METHODS FOR THE FLUOROMETRIC DETERMINATION OF THE ACTIVITY OF HYDROLASES, ESPECIALLY PENICILLIN G ACYLASE
US4853371A (en) 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
EP0258898B1 (en) * 1986-09-04 1992-04-22 Idemitsu Kosan Company Limited Liquid-crystalline polymer
US4810636A (en) 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
CS259396B1 (en) * 1987-05-06 1988-10-14 Jozef Luston 1,2,2,6,6-pentamethyl-4-(delta-bromalkoxy) piperidines and method of their preparation
SE8900130L (en) 1989-01-16 1989-01-16 Klaus Mosbach THE CONCEPT THAT USING MANUFACTURED ARTIFICIAL ANTIBODIES BY MOLECULE IMPRESSION METHOD BY IMPRINTING ANY ANTIGEN AND BY MANUFACTUREING ARTIFIED ENTYZYMES BY IMPRINTING
US5071469A (en) * 1989-04-21 1991-12-10 E. I. Du Pont De Nemours And Company Herbicidal benzylsulfonamides
US5498694A (en) * 1989-05-25 1996-03-12 La Jolla Cancer Research Foundation Peptides of the cytoplasmic domain of integrin
US5128247A (en) * 1989-08-14 1992-07-07 Board Of Regents, The University Of Texas System Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
US5099020A (en) * 1989-11-27 1992-03-24 Abbott Laboratories Barbiturate assay compositions and methods
ES2113940T3 (en) * 1990-12-03 1998-05-16 Genentech Inc ENRICHMENT METHOD FOR PROTEIN VARIANTS WITH ALTERED UNION PROPERTIES.
ATE180018T1 (en) * 1991-08-23 1999-05-15 Molecular Probes Inc USE OF HALOALKYL DERIVATIVES OF REPORTER MOLECULES FOR ANALYZING METABOLIC ACTIVITY IN CELLS
US5576424A (en) * 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
FR2700855B1 (en) * 1993-01-28 1995-03-03 Commissariat Energie Atomique Immunometric determination of an antigen or a hapten.
US5372944A (en) * 1993-10-14 1994-12-13 The Dow Chemical Company Method for conversion of halogenated hydrocarbons to halohydrins
US5523209A (en) * 1994-03-14 1996-06-04 The Scripps Research Institute Methods for identifying inhibitors of integrin activation
US5503977A (en) * 1994-04-22 1996-04-02 California Institute Of Technology Split ubiquitin protein sensor
JP3583489B2 (en) 1994-12-22 2004-11-04 日清紡績株式会社 Carbodiimide derivative
CH689633A5 (en) 1995-01-10 1999-07-30 Von Roll Umwelttechnik Ag Process for cooling and cleaning of flue gases.
AU730969B2 (en) * 1995-10-19 2001-03-22 University Of Washington Discrete-length polyethylene glycols
US6537776B1 (en) * 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5786428A (en) 1996-03-27 1998-07-28 California Institute Of Technology Adsorbents for amino acid and peptide separation
US6255461B1 (en) 1996-04-05 2001-07-03 Klaus Mosbach Artificial antibodies to corticosteroids prepared by molecular imprinting
US6162931A (en) 1996-04-12 2000-12-19 Molecular Probes, Inc. Fluorinated xanthene derivatives
US5945526A (en) * 1996-05-03 1999-08-31 Perkin-Elmer Corporation Energy transfer dyes with enhanced fluorescence
US6416733B1 (en) * 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US5853993A (en) * 1996-10-21 1998-12-29 Hewlett-Packard Company Signal enhancement method and kit
US5932421A (en) * 1996-12-06 1999-08-03 The Scripps Research Institute Methods and cell lines for identification of regulators of integrin activation
CA2281931A1 (en) 1997-02-13 1998-08-20 The Dow Chemical Company Recombinant haloaliphatic dehalogenases
US6333154B1 (en) * 1997-12-04 2001-12-25 Institut Pasteur Bacterial multi-hybrid system and applications thereof
US20020042055A1 (en) * 1999-12-23 2002-04-11 Affholter Joseph A. Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions
FR2804116B1 (en) * 2000-01-20 2002-08-23 Centre Nat Rech Scient ORGANOSILICATED COMPOUNDS, THEIR PREPARATION PROCESS AND THEIR USES
JP2003530365A (en) 2000-04-10 2003-10-14 ザ スクリプス リサーチ インスティチュート Proteomic analysis
AU2001296502B2 (en) 2000-10-02 2005-06-09 Molecular Probes, Inc. Reagents for labeling biomolecules having aldehyde or ketone moieties
US20020137171A1 (en) * 2000-12-01 2002-09-26 Diversa Corporation Hydrolase enzymes and their use in kinetic resolution
JP4589602B2 (en) 2000-12-01 2010-12-01 ヴェレニウム コーポレイション Enzyme having dehalogenase activity and method of using the same
WO2002059601A1 (en) * 2001-01-23 2002-08-01 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
DK1410023T3 (en) 2001-04-10 2006-10-09 Ecole Polytech Methods for using O-alkylguanine DNA alkyltransferases
GB0111987D0 (en) * 2001-05-16 2001-07-04 Univ Sheffield Method
AP2004003049A0 (en) 2001-11-08 2004-06-30 Elan Pharm Inc N,N' -substituted-1,3-diamino -2-hydroxypropane derivatives.
WO2004009788A2 (en) 2002-07-19 2004-01-29 Diversa Corporation Fluorescent proteins, nucleic acids encoding them and methods for making and using them
AU2003291151A1 (en) * 2002-11-22 2004-06-18 Carnegie Mellon University Compositions and methods for the reversible capture of biomolecules
WO2004072232A2 (en) 2003-01-31 2004-08-26 Promega Corporation Covalent tethering of functional groups to proteins
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
US20050095651A1 (en) * 2003-08-12 2005-05-05 The Regents Of The University Of California Photoswitchable method for the ordered attachment of proteins to surfaces
US20070087400A1 (en) * 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
US7425436B2 (en) * 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP1989548A2 (en) 2006-02-08 2008-11-12 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules
EP2087107A2 (en) * 2006-10-30 2009-08-12 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060415A1 (en) * 2000-02-18 2001-08-23 The Immune Response Corporation Methods and compositions for gene delivery

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Lecturer Abstracts", THE 2N SYMPOSIUM ON BIOLOGICAL IMAGING, 2003, XP002301487, Retrieved from the Internet <URL:http://www.promega-rd.info/bioimage2003/abstracts/lecturer/default.asp> [retrieved on 20041019] *
BARRETT A G M ET AL: "Synthesis and characterization of a new polymer support for a metallocene catalyst", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 58, no. 19, 6 May 2002 (2002-05-06), pages 3785 - 3792, XP004350403, ISSN: 0040-4020 *
CHEN CELIA C H ET AL: "Relocation of the catalytic carboxylate group in class A beta-lactamase: The structure and function of the mutant enzyme Glu166fwdarwGln:Asn170fwdarwAsp", PROTEIN ENGINEERING, vol. 12, no. 7, July 1999 (1999-07-01), pages 573 - 579, XP002301438, ISSN: 0269-2139 *
DATABASE EMBL EBI; XP002301439, Database accession no. BD057138 *
HYNKOVA K ET AL: "Identification of the catalytic triad in the haloalkane dehalogenase from Sphingomonas paucimobilis UT26", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 446, no. 1, 5 March 1999 (1999-03-05), pages 177 - 181, XP004259343, ISSN: 0014-5793 *
ICHIYAMA SUSUMU ET AL: "Novel catalytic mechanism of nucleophilic substitution by asparagine residue involving cyanoalanine intermediate revealed by mass spectrometric monitoring of an enzyme reaction", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 52, 29 December 2000 (2000-12-29), pages 40804 - 40809, XP002301434, ISSN: 0021-9258 *
KEPPLER ANTJE ET AL: "A general method for the covalent labeling of fusion proteins with small molecules in vivo", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 21, no. 1, 20 January 2003 (2003-01-20), pages 86 - 89, XP002231034, ISSN: 1087-0156 *
KULAKOVA A N ET AL: "The plasmid-located haloalkane dehalogenase gene from Rhodococcus rhodochrous NCIMB 13064", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 143, 1997, pages 109 - 115, XP002167049, ISSN: 1350-0872 *
KURIHARA TATSUO ET AL: "Comprehensive Site-Directed Mutagenesis of L-2-Halo Acid Dehalogenase to Probe Catalytic Amino Acid Residues", JOURNAL OF BIOCHEMISTRY (TOKYO), vol. 117, no. 6, 1995, pages 1317 - 1322, XP009038319, ISSN: 0021-924X *
PRIES FRENS ET AL: "Activation of an Asp-124 fwdarw Asn mutant of haloalkane dehalogenase by hydrolytic deamidation of asparagine", FEBS LETTERS, vol. 358, no. 2, 1995, pages 171 - 174, XP002301436, ISSN: 0014-5793 *
PRIES FRENS ET AL: "Histidine 289 is essential for hydrolysis of the alkyl-enzyme intermediate of haloalkane dehalogenase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 18, 1995, pages 10405 - 10411, XP002301486, ISSN: 0021-9258 *
YANG GUANG ET AL: "Identification of active site residues essential to 4-chlorobenzoyl-coenzyme A dehalogenase catalysis by chemical modification and site directed mutagenesis", BIOCHEMISTRY, vol. 35, no. 33, 1996, pages 10879 - 10885, XP002301437, ISSN: 0006-2960 *

Also Published As

Publication number Publication date
EP1594962B1 (en) 2014-08-27
US11028424B2 (en) 2021-06-08
KR20050109934A (en) 2005-11-22
EP2455458A2 (en) 2012-05-23
US10240184B2 (en) 2019-03-26
US20190218592A1 (en) 2019-07-18
US20040214258A1 (en) 2004-10-28
US20110201024A1 (en) 2011-08-18
US9540402B2 (en) 2017-01-10
US20120258470A1 (en) 2012-10-11
WO2004072232A2 (en) 2004-08-26
AU2004211584A1 (en) 2004-08-26
EP2455457B1 (en) 2015-03-11
US8921620B2 (en) 2014-12-30
JP2007524357A (en) 2007-08-30
US8257939B2 (en) 2012-09-04
EP2341134A2 (en) 2011-07-06
USRE42931E1 (en) 2011-11-15
US7867726B2 (en) 2011-01-11
US20120252048A1 (en) 2012-10-04
EP2455458A3 (en) 2013-04-24
JP4748685B2 (en) 2011-08-17
EP2369006B1 (en) 2014-03-12
EP2455457A3 (en) 2013-03-27
US20160031911A1 (en) 2016-02-04
CA2514564A1 (en) 2005-07-26
AU2004211584B2 (en) 2009-11-12
EP2341134A3 (en) 2011-08-31
US8895787B2 (en) 2014-11-25
EP2369006A1 (en) 2011-09-28
WO2004072232A9 (en) 2004-10-14
US20080026407A1 (en) 2008-01-31
US7238842B2 (en) 2007-07-03
US20170088877A1 (en) 2017-03-30
EP2341134B1 (en) 2014-08-27
EP1594962A2 (en) 2005-11-16
EP2455457A2 (en) 2012-05-23
EP2455458B1 (en) 2015-01-07

Similar Documents

Publication Publication Date Title
WO2004072232A3 (en) Covalent tethering of functional groups to proteins
WO2006093529A3 (en) Covalent tethering of functional groups to proteins and substrates therefor
EP2395358A3 (en) Covalent tethering of functional groups to proteins and substrates therefor
WO2003025154A3 (en) Methods and compositions for the construction and use of fusion libraries
DK1410023T3 (en) Methods for using O-alkylguanine DNA alkyltransferases
WO2003100021A3 (en) Methods and dna constructs for high yield production of polypeptides
WO2008019123A3 (en) Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
WO2003093448A3 (en) Recombinant glycosyltransferase fusion proteins
WO2005033094A3 (en) Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol
WO2002006457A3 (en) Novel lipase genes
WO2003072753A3 (en) Multimeric binding complexes
WO2005123913A3 (en) Reversibly modified thermostable enzyme compositions and methods of making and using the same
WO2005040107A3 (en) Methods for making simvastatin and intermediates
WO2006127822A3 (en) Scytovirin domain 1 related polypeptides
WO2005028615A3 (en) Methods and compositions for detecting promoter activity and expressing fusion proteins
WO2003062453A3 (en) Polycystic kidney disease nucleic acids and proteins
WO2004017042A3 (en) Methods and reagents for surface functionalization
WO2004058787A3 (en) Fluorogenic enzyme substrates and methods of preparation
WO2003100022A3 (en) Methods and dna constructs for high yield production of polypeptides
WO2003050265A3 (en) Compositions and methods for normalizing assays
WO2002042458A3 (en) G protein coupled receptors
WO2002000719A3 (en) Human and mouse g-protein couipled receptors
EP1515738A4 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
WO2005100386A3 (en) Canine cold-and menthol-sensitive receptor 1
WO2003000901A3 (en) Nucleic acids encoding protein kinases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/30-30/30, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2514564

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 200506120

Country of ref document: ZA

Ref document number: 1020057014186

Country of ref document: KR

Ref document number: 2006503174

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004211584

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004211584

Country of ref document: AU

Date of ref document: 20040130

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004211584

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 3867/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004707032

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 20048081944

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2004707032

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020057014186

Country of ref document: KR

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)